GCSF
2016/00711
Phase 3 small_molecule active
Quick answer
GCSF for End Stage Liver Disease is a Phase 3 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- End Stage Liver Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active